Navigation Links
Ebola Virus Thwarted After Exposure
Date:5/28/2010

Successful treatment in monkeys offers hope for humans, researchers say

FRIDAY, May 28 (HealthDay News) -- Researchers report that they've disrupted the ability of the Ebola virus to replicate in monkeys, potentially suggesting a treatment for humans who get infected with the lethal disease.

The study is the first to show that the treatment helps monkeys after exposure to the Ebola virus. Previous research showed that it worked when given as a vaccine before exposure.

The study, reported by Thomas W. Geisbert of Boston University School of Medicine and colleagues, focuses on bits of genetic material that target a protein that the virus needs to reproduce.

The notoriously deadly Ebola virus, found in Africa, causes massive bleeding and kills as many as 90 percent of the people it infects. Earlier this month, researchers reported that they'd created a vaccine that protects monkeys against three strains of the virus.

The findings were published May 27 in The Lancet.

More information

For more on research on Ebola fever and other acute viral diseases, see the National Institute of Allergy and Infectious Diseases.



-- Randy Dotinga



SOURCE: The Lancet, press release, May 27, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Experimental Vaccine Shields Monkeys Against Ebola
2. Scripps Research scientists reveal key structure from ebola virus
3. Anti-HIV Drugs May Help Prevent Spread of Virus
4. To attack H1N1, other flu viruses, gold nanorods deliver potent payload
5. Mount Sinai discovers bone marrow plays critical role in enhancing immune response to viruses
6. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
7. Doctors Can Use Rotavirus Vaccine Again: FDA
8. Rotavirus Vaccine Helps Kids Avoid Severe Gastro Illness
9. Study finds rotavirus vaccine greatly reduces hospitalizations for acute gastroenteritis in children
10. Mild-mannered metabolic helper rushes to fight invading viruses, researchers report
11. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: